Literature DB >> 20347873

Optimal promoter usage for lentiviral vector-mediated transduction of cultured central nervous system cells.

Mingjie Li1, Nada Husic, Ying Lin, Heather Christensen, Ibrahim Malik, Sally McIver, Christine M LaPash Daniels, David A Harris, Paul T Kotzbauer, Mark P Goldberg, B Joy Snider.   

Abstract

Lentiviral vectors transduce both dividing and non-dividing cells and can support sustained expression of transgenes. These properties make them attractive for the transduction of neurons and other neural cell types in vitro and in vivo. Lentiviral vectors can be targeted to specific cell types by using different promoters in the lentiviral shuttle vector. Even with identical constructs, however, levels of expression can vary significantly in different types of neurons and different culture preparations; expression levels in the same neuronal subtypes can be very different in primary cell culture and in vivo. We systematically assessed the ability of different promoters to direct expression of foreign transgenes in primary murine neocortical neurons, cerebellar granule cells and in undifferentiated and differentiated neuroblastoma cells. In primary cortical neurons, constructs using the ubiquitin C promoter directed the highest level of transgene expression; the phosphoglycerate kinase (PGK) promoter also directed robust transgene expression, while the cytomegalovirus (CMV) and MND (a synthetic promoter that contains the U3 region of a modified MoMuLV LTR with myeloproliferative sarcoma virus enhancer) promoters resulted in the expression of the transgenes in only limited number of neurons. In contrast, in cerebellar granule cells and in differentiated SH-SY5Y neuroblastoma cultures, the CMV promoter directed the most robust transgene expression. There was similar variability in transgene expression directed by these promoters in primary cultures of oligodendrocytes and astrocytes. These findings may prove useful in the design of lentiviral vectors for use in cell culture models of the nervous system. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347873      PMCID: PMC2864797          DOI: 10.1016/j.jneumeth.2010.03.019

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  41 in total

1.  Lentiviral gene transfer to the nonhuman primate brain.

Authors:  J H Kordower; J Bloch; S Y Ma; Y Chu; S Palfi; B Z Roitberg; M Emborg; P Hantraye; N Déglon; P Aebischer
Journal:  Exp Neurol       Date:  1999-11       Impact factor: 5.330

2.  Ribozyme-mediated inhibition of caspase-3 protects cerebellar granule cells from apoptosis induced by serum-potassium deprivation.

Authors:  B A Eldadah; R F Ren; A I Faden
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

3.  Characterization of promoter function and cell-type-specific expression from viral vectors in the nervous system.

Authors:  R L Smith; D L Traul; J Schaack; G H Clayton; K J Staley; C L Wilcox
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector.

Authors:  Zhennan Lai; Roscoe O Brady
Journal:  J Neurosci Res       Date:  2002-02-01       Impact factor: 4.164

5.  IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector.

Authors:  H Mizuguchi; Z Xu; A Ishii-Watabe; E Uchida; T Hayakawa
Journal:  Mol Ther       Date:  2000-04       Impact factor: 11.454

6.  Amyloid-beta peptides are cytotoxic to oligodendrocytes.

Authors:  J Xu; S Chen; S H Ahmed; H Chen; G Ku; M P Goldberg; C Y Hsu
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

7.  Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors.

Authors:  Carlos Lois; Elizabeth J Hong; Shirley Pease; Eric J Brown; David Baltimore
Journal:  Science       Date:  2002-01-10       Impact factor: 47.728

8.  Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins.

Authors:  Deborah J Watson; Gary P Kobinger; Marco A Passini; James M Wilson; John H Wolfe
Journal:  Mol Ther       Date:  2002-05       Impact factor: 11.454

9.  Characterization of lentiviral vector-mediated gene transfer in adult mouse brain.

Authors:  Veerle Baekelandt; Anje Claeys; Kristel Eggermont; Erwin Lauwers; Bart De Strooper; Bart Nuttin; Zeger Debyser
Journal:  Hum Gene Ther       Date:  2002-05-01       Impact factor: 5.695

10.  Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences.

Authors:  A Follenzi; L E Ailles; S Bakovic; M Geuna; L Naldini
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

View more
  24 in total

1.  Production of lentiviral vectors for transducing cells from the central nervous system.

Authors:  Mingjie Li; Nada Husic; Ying Lin; B Joy Snider
Journal:  J Vis Exp       Date:  2012-05-24       Impact factor: 1.355

2.  Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation.

Authors:  Jasbir Dalal; Jee Hoon Roh; Susan E Maloney; Afua Akuffo; Samir Shah; Han Yuan; Brie Wamsley; Wendell B Jones; Cristina de Guzman Strong; Paul A Gray; David M Holtzman; Nathaniel Heintz; Joseph D Dougherty
Journal:  Genes Dev       Date:  2013-02-21       Impact factor: 11.361

Review 3.  Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy.

Authors:  Sara Kathleen Powell; Ricardo Rivera-Soto; Steven James Gray
Journal:  Discov Med       Date:  2015-01       Impact factor: 2.970

4.  Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease.

Authors:  Ngoc B Lu-Nguyen; Martin Broadstock; Maximilian G Schliesser; Cynthia C Bartholomae; Christof von Kalle; Manfred Schmidt; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther       Date:  2014-04-15       Impact factor: 5.695

5.  Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Aβ uptake and degradation by astrocytes.

Authors:  Jacob M Basak; Philip B Verghese; Hyejin Yoon; Jungsu Kim; David M Holtzman
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

6.  Fast phasic release properties of dopamine studied with a channel biosensor.

Authors:  Geraldine J Kress; Hong-Jin Shu; Andrew Yu; Amanda Taylor; Ann Benz; Steve Harmon; Steven Mennerick
Journal:  J Neurosci       Date:  2014-08-27       Impact factor: 6.167

7.  Efficient Expression of Igf-1 from Lentiviral Vectors Protects In Vitro but Does Not Mediate Behavioral Recovery of a Parkinsonian Lesion in Rats.

Authors:  Ngoc B Lu-Nguyen; Martin Broadstock; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther       Date:  2015-10-01       Impact factor: 5.695

8.  Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males.

Authors:  Tao Sun; Nicole M Warrington; Jingqin Luo; Michael D Brooks; Sonika Dahiya; Steven C Snyder; Rajarshi Sengupta; Joshua B Rubin
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

9.  Characterization of the properties of seven promoters in the motor cortex of rats and monkeys after lentiviral vector-mediated gene transfer.

Authors:  Masae Yaguchi; Yohei Ohashi; Tadashi Tsubota; Ayana Sato; Kenji W Koyano; Ningqun Wang; Yasushi Miyashita
Journal:  Hum Gene Ther Methods       Date:  2013-10-22       Impact factor: 2.396

10.  Genetic manipulation of myoblasts and a novel primary myosatellite cell culture system: comparing and optimizing approaches.

Authors:  Melissa F Jackson; Knut E Hoversten; John M Powers; Grant D Trobridge; Buel D Rodgers
Journal:  FEBS J       Date:  2013-01-02       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.